Beta
197157

Effect of Curcumin and Ginger on Adverse Effects of Levofloxacin in Male Rats

Article

Last updated: 22 Jan 2023

Subjects

-

Tags

Academic and Pre-clinical Veterinary Sciences (Physiology, Histology, …rology, Parasitology, Pharmacology, Forensic Medicine and Toxicology)

Abstract

Fluoroquinolones are more likely than any other antibacterial drug classes to cause serious side effects. The purpose of this study is to assess the protective effects of vitamin E, curcumin, and ginger in male rats against the side effects of levofloxacin (LFX).Ninety male Wistar rats were placed into six groups, each of 15 animals. Groups 1 and 2 received distilled water or olive oil and kept as normal controls, while groups 3-6 received LFX [10 mg/kg body weight (BW)] alone or in combination with vitamin E (100 mg/kg BW.), curcumin (200 mg/kg BW.) or ginger (200 mg/kg BW.), respectively.  All medications were administered orally via gavage once a day for 5 successive days. Samples of blood were collected at zero day , 7th and 14th day post-treatments for biochemical analysis, while liver and kidney tissues were dissected and subjected to antioxidants estimation. Levofloxacin administration caused hepatic and renal damage evidenced by significant increase in serum liver enzymes, urea (76.43±3.70, 72.67±0.47, 75.00±6.42), creatinine (2.48±0.01, 2.48±0.01, 2.50±0.01), total cholesterol (166.67±6.81, 174.00±4.04, 176.00±2.88), triglycerides (269.67±5.84, 289.33± 4.91, 249.67±1.86), and low density lipoprotein- cholesterol (LDL- C) (243.00±7.09, 213.67± 5.03, 226.33±5.45) levels. Meanwhile, significant decline in serum levels of high density lipoprotein- cholesterol (HDL- C) (20.00±1.11, 23.33±3.38, 20.10±1.53), total protein (5.77±0.03, 5.97±0.09, 5.87±0.09), albumin (3.45±0.03, 3.60±0.06, 3.57±0.09)and A/G ratio (1.49±0.02, 1.51±0.05, 1.55±0.09) were determined in relation to normal control at zero, 7th and 14th day post-treatments, respectively in a time dependent manner. The superoxide dismutase (SOD) and glutathione peroxidase (GPx) activities in the liver (1.50±0.13, 1.67±0.18, 1.60±0.15; 2.02±0.38, 2.81±0.25, 3.30±0.37) and kidney (24.97±1.04, 21.33±1.33, 26.33±1.71; 3.15±0.14, 2.13±0.36, 2.44±0.28)tissues were significantly decreased in all levofloxacin- exposed rats compared to control values in the liver (3.00±0.11, 3.33±3.13, 3.33±0.16 for SOD; 19.76±0.03, 19.18±0.05,  18.42±0.13 for GPx) and kidney (71.33 ± 2.60, 67.67±0.88, 66.00±1.73 for SOD; 8.32±0.08, 8.30±0.04, 7.81±0.06 for GPx).  However, the hepatic and renal malondialdehyde (MDA) concentrations (74.51±0.69, 80.97±0.41, 95.88±0.52; 66.58±0.14, 65.09±0.12, 65.23±0.14) were significantly increased compared to the control (11.82±0.01, 11.82±0.001, 11.11±0.03; 30.88±0.03, 33.20±0.03, 32.83±0.04). Co-administration of LFX with vitamin E, curcumin or ginger attenuated the elevated liver enzymes, renal damage biomarkers, lipogram and hepato-renal MDA, with elevation of tissues antioxidants. From this study, biochemical results indicated that levofloxacin induced hepato-renal alterations in rats over time, and that curcumin or ginger medications may be more effective when used prophylactically rather than curatively.

DOI

10.21608/zvjz.2021.86165.1150

Keywords

Levofloxacin, Vitamin E, Curcumin, liver enzymes, antioxidants

Authors

First Name

Hosny

Last Name

Ibrahim

MiddleName

-

Affiliation

Pharmacology Department, Faculty of Veterinary Medicine, Zagazig University, 44511, Egypt

Email

dr.hibrahim951@yahoo.com

City

Sharkia

Orcid

-

First Name

Shimaa

Last Name

Shalaby

MiddleName

I

Affiliation

Physiology Department, Faculty of Veterinary Medicine, Zagazig University, 44511, Egypt

Email

siabdallah@zu.edu.eg

City

-

Orcid

-

First Name

Esraa

Last Name

Maghawry Abd-Allah El-Gazzar

MiddleName

-

Affiliation

Pharmacology Department, Faculty of Veterinary Medicine, Zagazig University, 44511, Egypt

Email

esraamaghawry2021@gmail.com

City

Zagazig

Orcid

-

Volume

49

Article Issue

3

Related Issue

27901

Issue Date

2021-09-01

Receive Date

2021-08-01

Publish Date

2021-09-01

Page Start

300

Page End

315

Print ISSN

1110-1458

Online ISSN

2357-075X

Link

https://zvjz.journals.ekb.eg/article_197157.html

Detail API

https://zvjz.journals.ekb.eg/service?article_code=197157

Order

6

Type

Original Article

Type Code

601

Publication Type

Journal

Publication Title

Zagazig Veterinary Journal

Publication Link

https://zvjz.journals.ekb.eg/

MainTitle

-

Details

Type

Article

Created At

22 Jan 2023